Nanoform Finland Oyj (HEL:NANOFH)

Market Cap	74.62M -11.4%
Revenue (ttm)	5.42M +19.9%
Net Income	-15.97M
EPS	-0.19
Shares Out	85.67M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	165,698
Average Volume	339,458
Open	0.8920
Previous Close	0.8820
Day's Range	0.8610 - 0.9060
52-Week Range	0.3770 - 1.3820
Beta	0.56
RSI	63.71
Earnings Date	May 19, 2026

About Nanoform Finland Oyj

Nanoform Finland Oyj engages in the provision of nanotechnology and drug particle engineering services for the pharma and biotech industries in Europe and the United States. The company provides nanoforming technologies, formulation, and analytical services, including controlled expansion of supercritical solutions technology that enables the creation of active pharmaceutical ingredients (API) nanoparticles directly from solution; biological nanoforming technology; and dosage forms of Nanoparticles. It also offers STARMAP, an AI platform predic...

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 2008
• Employees: 171
• Stock Exchange: Nasdaq Helsinki
• Ticker Symbol: NANOFH

Financial Performance

In 2025, Nanoform Finland Oyj's revenue was 5.02 million, an increase of 37.10% compared to the previous year's 3.66 million. Losses were -17.90 million, -23.60% less than in 2024.